Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.01.087PMID 17339069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines.

  2005cited by this paper
• Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.

  2003cited by this paper
• The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.

  2002cited by this paper
• Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

  2002cited by this paper
• CD4 T Cells Are the Only Lymphocytes Needed To Protect Mice against Rotavirus Shedding after Intranasal Immunization with a Chimeric VP6 Protein and the Adjuvant LT(R192G)

  2002cited by this paper
• Cell-Mediated Immunity Induced by Recombinant Mycobacterium bovis Bacille Calmette-Guérin Strains Against an Intracellular Bacterial Pathogen: Importance of Antigen Secretion or Membrane-Targeted Antigen Display as Lipoprotein for Vaccine Efficacy1

  2002cited by this paper
• Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus.

  2002cited by this paper
• Comparative evaluation of Mycobacterium vaccae as a surrogate cloning host for use in the study of mycobacterial genetics.

  2002cited by this paper
• Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in Mycobacterium bovis BCG strains.

  2002cited by this paper
• Plasmidic versus Insertional Cloning of Heterologous Genes in Mycobacterium bovis BCG: Impact on In Vivo Antigen Persistence and Immune Responses

  2002cited by this paper
• Protective Efficacy of Rotavirus 2/6-Virus-Like Particles Combined with CT-E29H, a Detoxified Cholera Toxin Adjuvant

  2001cited by this paper
• Rotavirus vaccine AVANT/GlaxoSmithKline.

  2001cited by this paper
• Lipoprotein Access to MHC Class I Presentation During Infection of Murine Macrophages with Live Mycobacteria1

  2001cited by this paper
• Recombinant BCG vaccines.

  2001cited by this paper
• Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: malE.

  2000cited by this paper
• Rotavirus Infection and Intussusception: A View from Retrospect

  2000cited by this paper
• An Essential Two-Component Signal Transduction System in Mycobacterium tuberculosis

  2000cited by this paper
• Heterotypic Protection and Induction of a Broad Heterotypic Neutralization Response by Rotavirus-Like Particles

  1999cited by this paper
• Antibody-Dependent and -Independent Protection following Intranasal Immunization of Mice with Rotavirus Particles

  1999cited by this paper
• Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein

  1999cited by this paper
• Humoral and Cellular Immune Responses in Mice Immunized with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Producing a Pertussis Toxin-Tetanus Toxin Hybrid Protein

  1999cited by this paper
• Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles.

  1999cited by this paper
• Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries.

  1999cited by this paper
• Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development.

  1999cited by this paper
• Construction and murine immunogenicity of recombinant Bacille Calmette Guérin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin.

  1999cited by this paper
• Rotavirus 2/6 Viruslike Particles Administered Intranasally with Cholera Toxin, Escherichia coli Heat-Labile Toxin (LT), and LT-R192G Induce Protection from Rotavirus Challenge

  1998cited by this paper
• Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium.

  1998cited by this paper
• Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development.

  1998cited by this paper
• Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity

  1998cited by this paper
• Identification of a T-helper cell epitope on the rotavirus VP6 protein

  1997cited by this paper
• Rotavirus virus-like particles administered mucosally induce protective immunity

  1997cited by this paper
• Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.

  1997cited by this paper
• CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice

  1997cited by this paper
• Mycobacterial promoters.

  1997cited by this paper
• Protective Effect of Rotavirus VP6-Specific IgA Monoclonal Antibodies That Lack Neutralizing Activity

  1996cited by this paper
• Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA

  1996cited by this paper
• Green fluorescent protein as a marker for gene expression and cell biology of mycobacterial interactions with macrophages

  1995cited by this paper
• Activity of mycobacterial promoters during intracellular and extracellular growth.

  1995cited by this paper
• Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG

  1995cited by this paper
• Rotavirus vaccines: success by reassortment?

  1994cited by this paper
• Identification of cytotoxic T cell epitopes on the VP3 and VP6 rotavirus proteins.

  1994cited by this paper
• Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A

  1994cited by this paper
• Stable integration and expression of the Plasmodium falciparum circumsporozoite protein coding sequence in mycobacteria.

  1993cited by this paper
• Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

  1993cited by this paper
• Oral immunization with recombinant BCG induces cellular and humoral immune responses against the foreign antigen.

  1993cited by this paper
• Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein.

  1991cited by this paper
• Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines

  1991cited by this paper
• New use of BCG for recombinant vaccines

  1991cited by this paper
• Basic methods in molecular biology

  1986cited by this paper

• Unleashing the power of the BCG vaccine in modulating viral immunity through heterologous protection: A scoping review

  2025cites this paper
• Recombinant Mycobacterium bovis BCG-Based HIV Vaccine: Failures and Promising Approaches for a Successful Vaccine Strategy

  2025cites this paper
• All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?

  2024cites this paper
• Engineering a dual vaccine against COVID-19 and tuberculosis

  2023cites this paper
• TỔNG QUAN: BỆNH ROTAVIRUS – BỆNH LÂY CHUNG Ở ĐỘNG VẬT VÀ NGƯỜI

  2023cites this paper
• The BCG Vaccine for COVID-19: First Verdict and Future Directions

  2021cites this paper
• The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview

  2021cites this paper
• Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens

  2020cites this paper
• MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice

  2019cites this paper
• Rotavirus VP6 as a potential vaccine candidate

  2019cites this paper
• Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity

  2018cites this paper
• Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned

  2018influential citation
• Austin Virology and Retro Virology Isolation and Molecular Characterization of a Porcine Rotavirus from Henan Province of China

  2017cites this paper
• Preclinical development of BCG.HIVA2auxo.int, harboring an integrative expression vector, for a HIV-TB Pediatric vaccine. Enhancement of stability and specific HIV-1 T-cell immunity

  2017cites this paper
• Recombinant BCG vaccines: molecular features and their influence in the expression of foreign genes

  2017cites this paper
• Expression of Cathepsin S in BCG converts it into a pro-apoptotic and highly immunogenic strain.

  2017cites this paper
• Engineering a pro-apoptotic BCG strain to improve efficacy of the current tuberculosis vaccine

  2017cites this paper
• The development of novel HIV-1 vaccines using modified recombinant BCG

  2016cites this paper
• Novel therapies and vaccines against the human respiratory syncytial virus

  2015cites this paper
• Rotavirus VP6 preparations as a non-replicating vaccine candidates.

  2015influential citation
• Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors

  2015cites this paper
• Respiratory Syncytial Virus: pathology, therapeutic drugs and prophylaxis.

  2014cites this paper
• Immunogenicity and protective efficacy of yeast extracts containing rotavirus-like particles: a potential veterinary vaccine.

  2014cites this paper
• Protective immunity induced by a recombinant BCG vaccine encoding the cyclophilin gene of Toxoplasma gondii.

  2013cites this paper
• Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8+ T Cells

  2012cites this paper
• Vaccine Design and Vaccination

  2012cites this paper
• Vasikan rotavirus-infektiot ja niiden ennaltaehkäisy ja kontrolli

  2012cites this paper
• Construction, stability and immunogenicity of recombinant BCG expressing HIV-1 subtype C gag under the control of MtrA promoter, with or without the leader sequences

  2011cites this paper
• EVALUATION OF A REVERSE TETRACYCLINE INDUCIBLE SYSTEM IN RECOMBINANT BCG TO IMPROVE STABILITY AND IMMUNOGENICITY

  2011cites this paper
• New Generation BCG Vaccines

  2011cites this paper
• Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

  2010cites this paper
• Stable expression of Leptospira interrogans antigens in auxotrophic Mycobacterium bovis BCG.

  2010cites this paper
• Optimisation of Bioluminescent Reporters for Use with Mycobacteria

  2010cites this paper
• Molecular Characterization of Heterologous HIV-1gp120 Gene Expression Disruption in Mycobacterium bovis BCG Host Strain: A Critical Issue for Engineering Mycobacterial Based-Vaccine Vectors

  2010cites this paper
• Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.

  2009cites this paper
• Recombinant Mycobacterium bovis BCG.

  2009cites this paper
• Optimisation of a mycobacterial replicon increases foreign antigen expression in mycobacteria.

  2009cites this paper
• Rotavirus diarrhea in bovines and other domestic animals

  2008cites this paper
• Rotavirus genotypes circulating in Brazil before national rotavirus vaccination: a review.

  2008cites this paper
• Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

  2008cites this paper
• Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.

  2008cites this paper